Arkolith/Insider Trading/CVKD/Form 4

Szot Matthew K

Chief Financial OfficerCadrenal Therapeutics, Inc. (CVKD) · full profile →Form 4 · filed Oct 7, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1K
Net Open-Market Flow
-$1K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 6, 2025Sell(S)107$13.99$1K17K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-25-097178) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML